Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as BtK inhibitors

4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as BtK inhibitors

US Patent 9790226 · Granted Oct 17, 2017

Estimated economic value: $91,258,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2025
(5,6-dihydro)pyrimido[4,5-e]indolizines2024
(5,6-dihydro)pyrimido[4,5-e]indolizines2024
Prognostic biomarkers for TTK inhibitor chemotherapy2024
Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]2023
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2023
Processed edible product comprising a polyelectrolyte complex and an antimicrobi2023
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor2023
(5,6-dihydro)pyrimido[4,5-E]indolizines2022
(5,6-dihydro)pyrimido[4,5-E]indolizines2022
Prognostic biomarkers for TTK inhibitor chemotherapy2021
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor2021